"Glucose" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement.
| Descriptor ID |
D005947
|
| MeSH Number(s) |
D09.947.875.359.448
|
| Concept/Terms |
Glucose- Glucose
- D-Glucose
- D Glucose
- Dextrose
|
Below are MeSH descriptors whose meaning is more general than "Glucose".
Below are MeSH descriptors whose meaning is more specific than "Glucose".
This graph shows the total number of publications written about "Glucose" by people in this website by year, and whether "Glucose" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 1 | 2 |
| 2000 | 0 | 1 | 1 |
| 2002 | 1 | 0 | 1 |
| 2004 | 0 | 1 | 1 |
| 2005 | 2 | 2 | 4 |
| 2006 | 1 | 1 | 2 |
| 2008 | 1 | 1 | 2 |
| 2009 | 1 | 0 | 1 |
| 2010 | 1 | 2 | 3 |
| 2011 | 1 | 0 | 1 |
| 2012 | 2 | 1 | 3 |
| 2013 | 0 | 1 | 1 |
| 2014 | 1 | 2 | 3 |
| 2015 | 0 | 2 | 2 |
| 2016 | 1 | 2 | 3 |
| 2017 | 46 | 68 | 114 |
| 2018 | 35 | 54 | 89 |
| 2019 | 9 | 24 | 33 |
| 2020 | 1 | 7 | 8 |
| 2021 | 1 | 7 | 8 |
To return to the timeline, click here.
Below are the most recent publications written about "Glucose" by people in Profiles.
-
Analysis of continuous glucose tracking data in people with type 1 diabetes after COVID-19 vaccination reveals unexpected link between immune and metabolic response, augmented by adjunctive oral medication. Int J Clin Pract. 2021 Dec; 75(12):e14714.
-
2-Deoxy-d-glucose exploits increased glucose metabolism in cancer and viral-infected cells: Relevance to its use in India against SARS-CoV-2. IUBMB Life. 2021 10; 73(10):1198-1204.
-
Causal role of frontal-midline theta in cognitive effort: a pilot study. J Neurophysiol. 2021 Oct 01; 126(4):1221-1233.
-
Short-term safety profile of Sars-Cov2 vaccination on glucose control: Continuous glucose monitoring data in people with autoimmune diabetes. Diabetes Res Clin Pract. 2021 Sep; 179:109022.
-
Cardiovascular drug therapy and surrogate COVID-19 outcomes: which is the impact of the "miraculous" sodium-glucose co-transporter-2 inhibitors? Kardiol Pol. 2021; 79(9):1048-1049.
-
Cardiovascular drug therapy and surrogate COVID-19 outcomes: which is the impact of the "miraculous" sodium-glucose co-transporter-2 inhibitors? Author's reply. Kardiol Pol. 2021; 79(9):1050-1051.
-
Considerations for best practices related to sodium-glucose cotransporter-2 inhibitors and serum potassium levels. Am J Health Syst Pharm. 2021 07 22; 78(15):1367-1368.
-
Corilagin and 1,3,6-Tri-O-galloy-ß-D-glucose: potential inhibitors of SARS-CoV-2 variants. Phys Chem Chem Phys. 2021 Jul 14; 23(27):14873-14888.
-
Wharton's Jelly Mesenchymal Stem Cell-Derived Extracellular Vesicles Reduce SARS-CoV2-Induced Inflammatory Cytokines Under High Glucose and Uremic Toxin Conditions. Stem Cells Dev. 2021 08 01; 30(15):758-772.
-
Glucose-lowering treatments and COVID-19 mortality in T2DM. Nat Rev Endocrinol. 2021 07; 17(7):387-388.